Back

Sangamo Therapeutics Quote, Financials, Valuation and Earnings

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.

Sell

SGMO
Sangamo Therapeutics

Last Price:

0.51

Seasonality Move:

1.35%

7 Day Trial

ALL ACCESS PASS

$ 7

NOW is the time to get in on this trillion-dollar megatrend

Get it here.

Sangamo Therapeutics Price Quote

$0.51

0.00 (-0.29%)

(Updated: April 22, 2024 at 6:55 PM ET)

Sangamo Therapeutics Key Stats

Sell

Sangamo Therapeutics (SGMO) is a Sell

Day range:

$0.47 - $0.53

52-week range:

$0.29 - $1.78

Dividend yield:

P/E ratio:

0.00

P/S ratio:

0.51

P/B ratio:

1.1%

Volume:

965.9K

Avg. volume:

1-year change:

-68.72%

Market cap:

$91.5M

Revenue:

$176.2M

EPS:

$-1.47

How Much Does Sangamo Therapeutics Make?

How Much Are Sangamo Therapeutics's Sales Annually?
SGMO Revenues are $176.2M
How Much Profit Does Sangamo Therapeutics's Make A Year?
SGMO net income is -$257.8M

Is Sangamo Therapeutics Growing As A Company?

What Is Sangamo Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.93%
What Is Sangamo Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Sangamo Therapeutics Stock Price Performance

Did Sangamo Therapeutics Stock Go Up Last Month?
Sangamo Therapeutics share price went down by -33.57% last month
Did SGMO's Share Price Rise Over The Last Year?
SGMO share price fell by -68.72% over the past 1 year

What Is Sangamo Therapeutics 52-Week High & Low?

What Is Sangamo Therapeutics’s 52-Week High Share Price?
Sangamo Therapeutics has traded as high as $1.78 over the past 52 weeks
What Is Sangamo Therapeutics’s 52-Week Low Share Price?
Sangamo Therapeutics has traded as low as $0.29 over the past 52 weeks

Sangamo Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sangamo Therapeutics?

How Much Debt Does Sangamo Therapeutics Have?
Total long term debt quarterly is $0
How Much Cash Does Sangamo Therapeutics Have?
Cash and short term investments quarterly total is $81M
What Is Sangamo Therapeutics’s Book Value Per Share?
Book value per share is 0.47

Is Sangamo Therapeutics Cash Flow Positive?

What Is SGMO Cash Flow From Operations?
Cash flow from operations (TTM) is -$224.8M
What Is Sangamo Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $14.6M
What Is Sangamo Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $153.5M

Sangamo Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
SGMO return on invested capital is -119.14%
What Is Sangamo Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -75.25%
What Is SGMO Return On Equity?
ROE is a measure of profitability and is -119.14%

Sangamo Therapeutics Earnings Date & Stock Price

What Is Sangamo Therapeutics's Stock Price Today?
A single share of SGMO can be purchased today for 0.51
What Is Sangamo Therapeutics’s Stock Symbol?
Sangamo Therapeutics trades on the nasdaq under the ticker symbol: SGMO
When Is Sangamo Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sangamo Therapeutics is scheduled on April 26, 2024
When Is SGMO's next ex-dividend date?
Sangamo Therapeutics's next ex-dividend date is April 23, 2024
How To Buy Sangamo Therapeutics Stock?
You can buy Sangamo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Sangamo Therapeutics Competitors

Who Are Sangamo Therapeutics's Competitors?
Below is a list of companies who compete with Sangamo Therapeutics or are related in some way:
- AIM ImmunoTech Inc (AIM)
- Armata Pharmaceuticals Inc (ARMP)
- Perspective Therapeutics Inc (CATX)
- Electromed Inc (ELMD)
- Protalix BioTherapeutics Inc (PLX)

Sangamo Therapeutics Dividend Yield